Kotak MF crosses 5 percent in Molbio Diagnostics via open market
MOLBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.0 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Kotak Mahindra Mutual Fund acquired 5,70,000 equity shares of Molbio Diagnostics on October 8, 2026 through open market purchases. Its holding rose from 4.99 percent (57.49 lakh shares) to 5.48 percent (63.19 lakh shares), crossing the 5 percent SAST disclosure threshold. The acquirer is not part of the promoter group. Total equity capital is 11.52 crore shares of Re 1 each.
Institutional buying by a major mutual fund signals confidence; crossing 5 percent triggers higher disclosure obligations under SEBI SAST rules.